Cargando…

Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine

BACKGROUND: In order to induce a potent and cross-reactive neutralizing antibody (nAb), an effective envelope immunogen is crucial for many viral vaccines, including the vaccine for the human immunodeficiency virus (HIV). The Chinese equine infectious anemia virus (EIAV) attenuated vaccine has contr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lianxing, Wan, Yanmin, Wu, Lan, Sun, Jianping, Li, Huiguang, Li, Haishan, Ma, Liying, Shao, Yiming
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940887/ https://www.ncbi.nlm.nih.gov/pubmed/20807451 http://dx.doi.org/10.1186/1742-4690-7-71

Ejemplares similares

Genetic Evolution during the development of an attenuated EIAV vaccine
por: Wang, Xue-Feng, et al.
Publicado: (2016)

ESCRT requirements for EIAV budding
por: Sandrin, Virginie, et al.
Publicado: (2013)

The Soluble Form of the EIAV Receptor Encoded by an Alternative Splicing Variant Inhibits EIAV Infection of Target Cells
por: Lin, Yue-Zhi, et al.
Publicado: (2013)

Infection of equine monocyte-derived macrophages with an attenuated equine infectious anemia virus (EIAV) strain induces a strong resistance to the infection by a virulent EIAV strain
por: Ma, Jian, et al.
Publicado: (2014)

Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain
por: Du, Jiansen, et al.
Publicado: (2014)

Analysis of the EIAV Rev-Responsive Element (RRE) Reveals a Conserved RNA Motif Required for High Affinity Rev Binding in Both HIV-1 and EIAV
por: Lee, Jae-Hyung, et al.
Publicado: (2008)

Assessment of Integration-defective HIV-1 and EIAV Vectors In Vitro and In Vivo
por: Ellis, Scott, et al.
Publicado: (2012)

The Neutralizing Face of Hepatitis C Virus E2 Envelope Glycoprotein
por: Tzarum, Netanel, et al.
Publicado: (2018)

Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
por: Torrents de la Peña, Alba, et al.
Publicado: (2018)

Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
por: Gnanakaran, S., et al.
Publicado: (2010)

P05-10. Sequential immunization with a subtype B HIV-1 envelope quasispecies elicits broader neutralization than vaccination with a single envelope clone
por: Malherbe, DC, et al.
Publicado: (2009)

Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense
por: Wang, Yan, et al.
Publicado: (2022)

Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity
por: Zhang, Dai, et al.
Publicado: (2019)

Envelope Glycoprotein of Arenaviruses
por: Burri, Dominique J., et al.
Publicado: (2012)

Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers
por: Schorcht, Anna, et al.
Publicado: (2020)

Characterization of EIAV env Quasispecies during Long-Term Passage In Vitro: Gradual Loss of Pathogenicity
por: Liu, Cong, et al.
Publicado: (2019)

HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
por: van den Kerkhof, Tom L G M, et al.
Publicado: (2013)

Enhancing anti-viral neutralization response to immunization with HIV-1 envelope glycoprotein immunogens
por: Ahmed, Shamim, et al.
Publicado: (2023)

Structures of immature EIAV Gag lattices reveal a conserved role for IP6 in lentivirus assembly
por: Dick, Robert A., et al.
Publicado: (2020)

Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
por: El Abd, Yasmine S, et al.
Publicado: (2011)

Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
por: Lacerda, Miguel, et al.
Publicado: (2013)

Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins
por: Liu, Xiao-Qin, et al.
Publicado: (2018)

Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein
por: Grunst, Michael W., et al.
Publicado: (2023)

Membrane Glycoproteins of Enveloped Viruses
por: Compans, Richard W., et al.
Publicado: (1978)

A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies
por: Davis-Gardner, Meredith E., et al.
Publicado: (2020)

Reverted HIV-1 Mutants in CD4(+) T-Cells Reveal Critical Residues in the Polar Region of Viral Envelope Glycoprotein
por: Lu, Wuxun, et al.
Publicado: (2021)

A Weak Neutralizing Antibody Response to Hepatitis C Virus Envelope Glycoprotein Enhances Virus Infection
por: Meyer, Keith, et al.
Publicado: (2011)

Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies
por: Boutin, Marianne, et al.
Publicado: (2022)

New Neutralizing Epitope Exposed on the Domain II of Tick-Borne Encephalitis Virus Envelope Glycoprotein E
por: Matveev, Andrey, et al.
Publicado: (2023)

Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted / founder sensitivity to broadly neutralizing antibodies
por: Ratnapriya, Sneha, et al.
Publicado: (2023)

Envelope glycoprotein interactions in coronavirus assembly
Publicado: (1995)

HCMV Envelope Glycoprotein Diversity Demystified
por: Foglierini, Mathilde, et al.
Publicado: (2019)

The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework
por: Vallejo-Torres, Laura
Publicado: (2023)

An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family
por: Craigo, Jodi K, et al.
Publicado: (2009)

Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation
Publicado: (1996)

Neutralizing Antibody Responses in Macaques Induced by Human Immunodeficiency Virus Type 1 Monovalent or Trivalent Envelope Glycoproteins
por: Quinnan, Gerald V., et al.
Publicado: (2013)

Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques
por: Klasse, P. J., et al.
Publicado: (2018)

Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
por: van Schooten, Jelle, et al.
Publicado: (2022)

HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds
por: van den Kerkhof, Tom L. G. M., et al.
Publicado: (2016)

HIV-1 Envelope Glycoprotein Variable Loops Are Indispensable for Envelope Structural Integrity and Virus Entry
por: Yuan, Tingting, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m2fsu880nr29ne5iipucjkggq4